Prof Ana Santos Rutschman talks about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Recent popular interest in Henrietta Lacks has prompted interest in better engaging AA nurses and communities.

One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable.

Would you question health decisions made by a 37-year old Black woman whose great-grandfather died in the US Public Health Service Syphilis Study at Tuskegee?

Dr Steven Goodman talks about the ethical and scientific implications of breaking the blind of placebo-controlled COVID-19 vaccine trials.

Concepts of “governance,” “trust,” and “culture” can help strengthen research partnerships, honor tribal sovereign authority, counter histories of opportunism, and recognize alternative ways of knowing.

How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?

Clinicians should have a working understanding of gene editing, controversy surrounding its use, and its far-reaching clinical and ethical implications.

In the past decade, more students than ever entered medical school with the desire, if not the expectation, of participating in meaningful global health experiences.

Four MDGs directly concern public health, and public health schools should be involved in meeting them.